Empagliflozin Reduces the Risk of a Broad Spectrum of Heart Failure Outcomes Regardless of Heart Failure Status at Baseline
European Journal of Heart Failure - United States
doi 10.1002/ejhf.1419
Full Text
Open PDFAbstract
Available in full text
Date
February 14, 2019
Authors
Publisher
Wiley